Caroline Pandolfi

Connecticut Oncology GroupMiddletown, Connecticut - 06457 |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS1
- SINCE2010

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)
June 2010 - April 2015
Lymphoma
Lymphoma, Non-Hodgkin
Lymphoma, B-Cell
Bendamustine And Ofatumumab



